InjectCo believes in transparent pricing for all prescription peptide therapies always
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, parallel-group, phase 3 trial
When It Warrants a Call Fatigue that is persistent, worsening, or accompanied by other symptoms lightheadedness, an inability to keep fluids down, severe or continuing abdominal pain, or changes in urination is a reason to contact the prescriber rather than wait it out
Pick up your Mounjaro prescription, if prescribed
Weight-loss meds may give people more control over drinking, study shows Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped heavy drinkers cut alcohol consumption by nearly 70%
Renowned physicians, including Dr